RapV12 antagonizes Ras‐dependent activation of ERK1 and ERK2 by LPA and EGF in Rat‐1 fibroblasts.

Simon J. Cook(Eloxx Pharmaceuticals (United States)), Bonnee Rubinfeld(Eloxx Pharmaceuticals (United States)), Iris Albert(Eloxx Pharmaceuticals (United States)), Frank McCormick(Eloxx Pharmaceuticals (United States))
The EMBO Journal
September 1, 1993
Cited by 352Open Access
Full Text

Abstract


Related Papers